• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: a health economic literature review
2013     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation and impact of a primary care-based telemonitoring intervention in home care patients with heart failure or chronic lung disease. Randomised controlled trial. The TELBIL study]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vildagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2013     Basque Office for Health Technology Assessment (OSTEBA) [Individualised multidisciplinary care programme in frail patients (PAMI)]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Biologic medications as second-line therapy for rheumatoid arthritis]
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bosutinib - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2013     The Swedish Council on Health Technology Assessment (SBU) [Diagnosis and treatment of ADHD and ASDs (autism spectrum disorders)]
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013     HAYES, Inc. SensiGene fetal RHD genotyping
2013     University of York Inpatient rehabilitation services for the frail elderly
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ocriplasmin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Agency for Healthcare Research and Quality (AHRQ) Pulmonary arterial hypertension: screening, management, and treatment
2013     Health Quality Ontario (HQO) Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013     University of York Evidence briefing on non-pharmacological interventions for dementia in care home settings
2013     Institute for Clinical and Economic Review (ICER) Cardiac nuclear imaging
2013     Basque Office for Health Technology Assessment (OSTEBA) [Alternatives to short stay psychiatric hospitalisation. Intensive ambulatory monitoring programmes]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linaclotide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013     University of York Telehealth for patients with long term conditions
2013     Institute for Clinical and Economic Review (ICER) Cervical spinal fusion for degenerative disc disease
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-09 (vandetanib)]
2013     Health Quality Ontario (HQO) OHTAC recommendation: endovascular ablation for varicose veins
2013     NIHR Horizon Scanning Centre (NIHR HSC) The SurroSense Rx™ System for prevention of diabetic foot ulcers
2013     University of York Evidence briefing on urgent care systems
2013     Basque Office for Health Technology Assessment (OSTEBA) [Quality of life of stroke patients and their caregivers. Prognosis and results of rehabilitating treatment]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-10 (pertuzumab)]
2013     Health Quality Ontario (HQO) Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013     NIHR Horizon Scanning Centre (NIHR HSC) ATI™ Neurostimulation System for cluster headache
2013     University of York Consolidating urgent care services
2013     Basque Office for Health Technology Assessment (OSTEBA) [Redesigning maternal education: proposal for a framework to draw up an education programme for health and effective birth preparation focused on the needs of women]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lisdexamfetamine - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous coronary intervention for chronic total occlusion]
2013     Health Quality Ontario (HQO) OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ellex 2RT™ for early age-related macular degeneration
2013     University of York Advance care planning
2013     Basque Office for Health Technology Assessment (OSTEBA) [A study of the use of clinical practice guidelines in specialized care: barriers and facilitators to implementation]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-03 (sitagliptin/metformin)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Implantation of a lumbar artificial endoprosthesis (anuloplasty/anular repair device)]
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) OssDsign™ Cranio PSI for skull repair
2013     University of York Primary care 'in-reach' in hospital settings
2013     Basque Office for Health Technology Assessment (OSTEBA) [Design of an interaction protocol between Primary Care and Hospitals to improve early detection and monitoring of patients with multiple sclerosis]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-16 (vildagliptin)]
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Neurodevelopmental outcome after neonatal hypoglycemia: a multi-center randomized controlled trial comparing intensive treatment versus expectant glucose monitoring in 'high risk' newborns]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Repair of cartilage defects via matrix-associated autologous chondrocyte immigration]
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013     NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013     Medical Services Advisory Committee (MSAC) Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013     Basque Office for Health Technology Assessment (OSTEBA) [Terminal care: systematic review of organisational models in palliative care and survey of health professionals regarding the situation of palliative care in a region of the Basque Country]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-17 (vildagliptin/metformin)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)]
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Smart-Glasses depth-based visual aids for the partially sighted
2013     Medical Services Advisory Committee (MSAC) Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013     Basque Office for Health Technology Assessment (OSTEBA) [Results of the perinatal care of very premature children in the health system of the Basque Country]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Endovascular repair of aortic aneurysms]
2013     NIHR Horizon Scanning Centre (NIHR HSC) Full Sense™ device for obesity
2013     Medical Services Advisory Committee (MSAC) Transcatheter closure of patent ductus arteriosus
2013     Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the status, systematic review and validation of a diagnostic algorithm for pulmonary thromboembolism (PTE) in the hospital emergency services of the Basque Health Service]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013     Medical Services Advisory Committee (MSAC) Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
2013     Basque Office for Health Technology Assessment (OSTEBA) [Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponatinib - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM)]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013     Medical Services Advisory Committee (MSAC) Matrix-induced autologous chondrocyte implant
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vismodegib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013     Medical Services Advisory Committee (MSAC) Sexual health medicine consultation items
2013     Basque Office for Health Technology Assessment (OSTEBA) [Hemoperfusion with polymyxin-B for the treatment of sepsis of abdominal origin by gram negative microorganisms]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of new and relevant recommendations, for the DMP "COPD"]
2013     Adelaide Health Technology Assessment (AHTA) Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Copper intra-uterine devices as a contraceptive for adult women: a review of clinical effectiveness and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
2013     Medical Services Advisory Committee (MSAC) Addiction medicine consultation items
2013     Basque Office for Health Technology Assessment (OSTEBA) [CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pomalidomide - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment))]
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Pharmacogenetic testing in the clinical setting: is screening for TPMT genotype a cost-effective treatment strategy? The first prospective randomized controlled trial within the Dutch health care system]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [P16/Ki-67 dual stain in the triage of PAPIII/IIID cytology in cervical cancer screening]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the prevention or management of childhood obesity: a review of the clinical evidence
2013     Medical Services Advisory Committee (MSAC) Genetic testing for hereditary mutations in the RET gene
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of new and relevant recommendations, for the DMP "asthma"]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pomalidomide (Pomalyst®) for the treatment of refractory multiple myeloma or relapsed and refractory multiple myeloma
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transobturator slings for urinary incontinence: clinical effectiveness and guidelines
2013     Medical Services Advisory Committee (MSAC) Implantation of fiducial markers into the prostate gland or prostate surgical bed for external beam radiotherapy
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Regorafenib (Stivarga®) in pts with metastatic colorectal cancer (CRC) who have progressed after standard therapy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines